Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1017/S0022215120001863 http://scihub22266oqcxt.onion/10.1017/S0022215120001863 32838816!7468789!32838816     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32838816&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Laryngol+Otol 2020 ; 134 (8): 717-720 Nephropedia Template TP {{tp|p=32838816|t=2020. Epistaxis as a marker for severe acute respiratory syndrome coronavirus-2 status - a prospective study |pdf=|usr=}}{{32838816}} gab.com Text Epistaxis as a marker for severe acute respiratory syndrome coronavirus-2 status - a prospective study JO: J Laryngol Otol http://www.kidney.de/pget.php?&tw=1&pmid=32838816 #FOAvip OBJECTIVE: To evaluate the prevalence of severe acute respiratory syndrome coronavirus-2 infection in patients presenting with epistaxis to a tertiary otolaryngology unit. METHODS: A prospective study was conducted of 40 consecutive patients presenting with epistaxis referred to our tertiary otolaryngology unit. A group of 40 age-matched controls were also included. All patients underwent real-time reverse transcriptase polymerase chain reaction testing for severe acute respiratory syndrome coronavirus-2. Symptoms of fever, cough and anosmia were noted in the study group. RESULTS: The mean age was 66.5 +/- 22.4 years in the study group. There were 22 males (55 per cent) and 18 females (45 per cent). The mean age in the control group was 66.3 +/- 22.4 years (p = 0.935). There were six positive cases for severe acute respiratory syndrome coronavirus-2 (15 per cent) in the epistaxis group and one case (2.5 per cent) in the control group. The difference was statistically significant (p = 0.05). CONCLUSION: Epistaxis may represent a presenting symptom of severe acute respiratory syndrome coronavirus-2 infection. This may serve as a useful additional criterion for screening patients. Twit Text FOAVip Epistaxis as a marker for severe acute respiratory syndrome coronavirus-2 status - a prospective study ????J Laryngol Otol http://www.kidney.de/pget.php?&tw=1&pmid=32838816 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32838816 #FOAvip English Wikipedia <ref>{{Cite pmid|32838816}}</ref> Epistaxis as a marker for severe acute respiratory syndrome coronavirus-2 status - a prospective study #MMPMID32838816 Hussain MH; Mair M; Rea P J Laryngol Otol 2020[Aug]; 134 (8): 717-720 PMID32838816show ga OBJECTIVE: To evaluate the prevalence of severe acute respiratory syndrome coronavirus-2 infection in patients presenting with epistaxis to a tertiary otolaryngology unit. METHODS: A prospective study was conducted of 40 consecutive patients presenting with epistaxis referred to our tertiary otolaryngology unit. A group of 40 age-matched controls were also included. All patients underwent real-time reverse transcriptase polymerase chain reaction testing for severe acute respiratory syndrome coronavirus-2. Symptoms of fever, cough and anosmia were noted in the study group. RESULTS: The mean age was 66.5 +/- 22.4 years in the study group. There were 22 males (55 per cent) and 18 females (45 per cent). The mean age in the control group was 66.3 +/- 22.4 years (p = 0.935). There were six positive cases for severe acute respiratory syndrome coronavirus-2 (15 per cent) in the epistaxis group and one case (2.5 per cent) in the control group. The difference was statistically significant (p = 0.05). CONCLUSION: Epistaxis may represent a presenting symptom of severe acute respiratory syndrome coronavirus-2 infection. This may serve as a useful additional criterion for screening patients. |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Betacoronavirus/*genetics/isolation & purification[MESH] |COVID-19[MESH] |Case-Control Studies[MESH] |Coronavirus Infections/*complications/drug therapy/*epidemiology/virology[MESH] |Cough/diagnosis/virology[MESH] |Epistaxis/*diagnosis/epidemiology/virology[MESH] |Female[MESH] |Fever/diagnosis/virology[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Olfaction Disorders/diagnosis/virology[MESH] |Otolaryngology/standards[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/drug therapy/*epidemiology/virology[MESH] |Prevalence[MESH] |Prospective Studies[MESH] |Real-Time Polymerase Chain Reaction[MESH] |SARS-CoV-2[MESH] |Tertiary Care Centers/standards[MESH]Epistaxis as a marker for severe acute respiratory syndrome coronaviru(epmc).pdf DeepDyve Pubget Overpricing